Variant report

Variant	nsv880436
Chromosome Location	chr5:4982643-5038540
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:373)
CpG islands
(count:732)
Chromatin interactive
region (count:9)
LncRNA
region (count:13)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:373 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr5:5037697-5038236	GM12878	blood:	n/a	n/a
2	ATF2	chr5:5006468-5007306	GM12878	blood:	n/a	n/a
3	ATF2	chr5:5006520-5007114	GM12878	blood:	n/a	n/a
4	ATF2	chr5:5026064-5026628	GM12878	blood:	n/a	n/a
5	ATF2	chr5:5037602-5038121	GM12878	blood:	n/a	n/a
6	BATF	chr5:5037758-5038125	GM12878	blood:	n/a	chr5:5037962-5037973
7	BATF	chr5:5025857-5026414	GM12878	blood:	n/a	chr5:5026204-5026212
8	BATF	chr5:5006737-5006996	GM12878	blood:	n/a	n/a
9	BATF	chr5:5037853-5038082	GM12878	blood:	n/a	chr5:5037962-5037973
10	BATF	chr5:5008497-5008846	GM12878	blood:	n/a	n/a
11	BATF	chr5:5026111-5026335	GM12878	blood:	n/a	chr5:5026204-5026212
12	BATF	chr5:5018336-5018764	GM12878	blood:	n/a	chr5:5018561-5018572
13	BCL3	chr5:5006634-5006909	GM12878	blood:	n/a	n/a
14	BCL3	chr5:5018408-5018770	GM12878	blood:	n/a	n/a
15	BCL3	chr5:5006445-5007314	GM12878	blood:	n/a	n/a
16	BCL3	chr5:5026116-5026443	GM12878	blood:	n/a	chr5:5026249-5026258
17	BCL3	chr5:5017326-5017692	GM12878	blood:	n/a	n/a
18	BCL3	chr5:5008452-5008803	GM12878	blood:	n/a	n/a
19	BCL3	chr5:5014454-5015662	GM12878	blood:	n/a	chr5:5015090-5015099
20	BCLAF1	chr5:5037670-5038110	GM12878	blood:	n/a	n/a
21	BHLHE40	chr5:5026232-5026399	GM12878	blood:	n/a	n/a
22	CEBPB	chr5:4988071-4988204	A549	lung:	n/a	chr5:4988140-4988151
23	CEBPB	chr5:4994964-4995556	A549	lung:	n/a	chr5:4995214-4995225
24	CEBPB	chr5:4995034-4995411	H1-hESC	embryonic stem cell:	n/a	chr5:4995214-4995225
25	CEBPB	chr5:5024552-5024779	A549	lung:	n/a	chr5:5024686-5024697
26	CEBPB	chr5:4995015-4995510	Hela-S3	cervix:	n/a	chr5:4995214-4995225
27	CEBPB	chr5:4995023-4995586	K562	blood:	n/a	chr5:4995214-4995225
28	CEBPB	chr5:4995024-4995411	A549	lung:	n/a	chr5:4995214-4995225
29	CEBPB	chr5:4995014-4995486	MCF-7	breast:	n/a	chr5:4995214-4995225
30	CEBPB	chr5:5024698-5024707	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr5:4995028-4995414	IMR90	lung:	n/a	chr5:4995214-4995225
32	CEBPB	chr5:4995046-4995468	A549	lung:	n/a	chr5:4995214-4995225
33	CEBPB	chr5:5024630-5024793	HepG2	liver:	n/a	chr5:5024686-5024697
34	CEBPB	chr5:4995084-4995221	HepG2	liver:	n/a	n/a
35	CEBPB	chr5:5002590-5002823	HepG2	liver:	n/a	chr5:5002697-5002708
36	CEBPB	chr5:4995031-4995356	K562	blood:	n/a	chr5:4995214-4995225
37	CEBPB	chr5:4995063-4995341	K562	blood:	n/a	chr5:4995214-4995225
38	CEBPB	chr5:4995015-4995503	MCF-7	breast:	n/a	chr5:4995214-4995225
39	CEBPB	chr5:4995028-4995409	HepG2	liver:	n/a	chr5:4995214-4995225
40	CEBPB	chr5:4995111-4995389	ECC-1	luminal epithelium:	n/a	chr5:4995214-4995225
41	CEBPB	chr5:5024651-5024667	K562	blood:	n/a	n/a
42	CEBPB	chr5:4987798-4988222	K562	blood:	n/a	chr5:4988140-4988151
43	CEBPB	chr5:4995070-4995393	ECC-1	luminal epithelium:	n/a	chr5:4995214-4995225
44	CEBPB	chr5:4987976-4988319	HepG2	liver:	n/a	chr5:4988140-4988151
45	CEBPB	chr5:5006611-5007165	GM12878	blood:	n/a	n/a
46	CHD2	chr5:5031782-5032140	K562	blood:	n/a	n/a
47	CTCF	chr5:5025200-5025350	MCF-7	breast:	n/a	n/a
48	CTCF	chr5:5025129-5025222	MCF-7	breast:	n/a	chr5:5025172-5025193 chr5:5025177-5025195 chr5:5025183-5025192
49	CTCF	chr5:5025154-5025194	MCF-7	breast:	n/a	chr5:5025172-5025193 chr5:5025183-5025192
50	CTCF	chr5:5025100-5025250	SK-N-SH_RA	brain:	n/a	chr5:5025172-5025193 chr5:5025177-5025195 chr5:5025183-5025192

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:5033311-5033361	GM06990	blood:	n/a
2	chr5:5033993-5034043	A549	lung:	n/a
3	chr5:5033782-5033832	AG09319	gingival:	n/a
4	chr5:5034274-5034324	AG09309	skin:	n/a
5	chr5:5025912-5025962	PrEC	prostate:	n/a
6	chr5:5033311-5033361	HNPCEpiC	eye:	n/a
7	chr5:5033993-5034043	HCM	heart:	n/a
8	chr5:5025803-5025853	HRCEpiC	kidney:	n/a
9	chr5:5034303-5034353	HUVEC	blood vessel:	n/a
10	chr5:5033782-5033832	GM19239	blood:	n/a
11	chr5:5034356-5034406	NH-A	brain:	n/a
12	chr5:5025912-5025962	HRE	kidney:	n/a
13	chr5:5033311-5033361	HAEpiC	amniotic membrane:	n/a
14	chr5:5025803-5025853	PANC-1	pancreas:	n/a
15	chr5:5034356-5034406	T-47D	breast:	n/a
16	chr5:5033993-5034043	LNCaP	prostate:	n/a
17	chr5:5025912-5025962	NT2-D1	testis:	n/a
18	chr5:5034397-5034447	T-47D	breast:	n/a
19	chr5:5033763-5033813	Caco-2	colon:	n/a
20	chr5:5034361-5034411	HCT-116	colon:	n/a
21	chr5:5025848-5025898	IMR90	lung:	fetal
22	chr5:5025848-5025898	HRCEpiC	kidney:	n/a
23	chr5:5034274-5034324	HL-60	blood:	n/a
24	chr5:5033993-5034043	NB4	blood:	n/a
25	chr5:5033782-5033832	Hepatocyte	liver:	n/a
26	chr5:5034303-5034353	HIPEpiC	eye:	n/a
27	chr5:5034361-5034411	GM12891	blood:	n/a
28	chr5:5033311-5033361	K562	blood:	n/a
29	chr5:5034397-5034447	HepG2	liver:	n/a
30	chr5:5033993-5034043	Caco-2	colon:	n/a
31	chr5:5025803-5025853	SK-N-SH	brain:	n/a
32	chr5:5034361-5034411	BJ	skin:	n/a
33	chr5:5025848-5025898	H1-hESC	embryonic stem cell:	embryo
34	chr5:5034303-5034353	HMEC	breast:	n/a
35	chr5:5034303-5034353	SKMC	muscle:	n/a
36	chr5:5034397-5034447	MCF-7	breast:	n/a
37	chr5:5034303-5034353	HCT-116	colon:	n/a
38	chr5:5033763-5033813	HL-60	blood:	n/a
39	chr5:5034397-5034447	SK-N-SH_RA	brain:	n/a
40	chr5:5033993-5034043	NT2-D1	testis:	n/a
41	chr5:5034361-5034411	GM19239	blood:	n/a
42	chr5:5033763-5033813	GM12892	blood:	n/a
43	chr5:5025848-5025898	SK-N-MC	brain:	n/a
44	chr5:5034356-5034406	SK-N-SH_RA	brain:	n/a
45	chr5:5025803-5025853	AoSMC	blood vessel:	n/a
46	chr5:5034274-5034324	NH-A	brain:	n/a
47	chr5:5025848-5025898	Caco-2	colon:	n/a
48	chr5:5025848-5025898	NT2-D1	testis:	n/a
49	chr5:5033311-5033361	NHBE	bronchial:	n/a
50	chr5:5034274-5034324	NB4	blood:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:5021569..5024371-chr5:5031180..5034159,2	K562	blood:
2	chr5:5016117..5018968-chr5:5021980..5023753,2	K562	blood:
3	chr5:5017671..5019822-chr5:5068960..5071116,2	MCF-7	breast:
4	chr5:5021569..5024371-chr5:5031180..5034159,2	K562	blood:
5	chr5:5013892..5018267-chr5:5019017..5021975,4	K562	blood:
6	chr5:4989838..4992818-chr5:5420567..5423563,2	K562	blood:
7	chr5:5016117..5018968-chr5:5021980..5023753,2	K562	blood:
8	chr5:5013892..5018267-chr5:5019017..5021975,4	K562	blood:
9	chr5:5008094..5008743-chr5:62214886..62215776,2	K562	blood:

(count:13 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MED10-9	chr5:5034246-5034382	NONHSAT100153
2	lnc-MED10-9	chr5:5021328-5021834	NONHSAT100153
3	lnc-MED10-9	chr5:5021742-5021834	XLOC_004717
4	lnc-ADAMTS16-1	chr5:5034472-5034650	ENSG00000215231
5	lnc-ADAMTS16-1	chr5:5034472-5034650	XLOC_004269
6	lnc-ADAMTS16-1	chr5:5034472-5034650	NONHSAT100155
7	lnc-MED10-9	chr5:5034246-5034337	XLOC_004717
8	lnc-ADAMTS16-1	chr5:4987238-4987943	NONHSAT100152
9	lnc-MED10-9	chr5:5021671-5021834	XLOC_004717
10	lnc-ADAMTS16-1	chr5:5034476-5034650	XLOC_004269
11	lnc-ADAMTS16-1	chr5:5034472-5034650	XLOC_004269
12	lnc-ADAMTS16-1	chr5:5034576-5034650	ENSG00000215231
13	lnc-MED10-9	chr5:5034246-5034380	XLOC_004717

No data

Variant related genes	Relation type
LINC01020	TF binding region
ENSG00000250481	TF binding region
LINC01020	CpG island
ENSG00000250481	CpG island
ENSG00000164151	chromatin interactions
WDR37	miRNA target sites
BRD3	miRNA target sites

Extended variants
information (count: 1702 )
Associated
traits (count: 94 )

Variant overlapped rSNPs/rCNVs (count:1702 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs30472	chr5:4982643-4982644	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs369657454	chr5:4982653-4982654	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs139749499	chr5:4982669-4982670	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs201605310	chr5:4982678-4982679	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs200128992	chr5:4982680-4982681	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs540673380	chr5:4982681-4982682	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs560928105	chr5:4982682-4982683	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs529857641	chr5:4982739-4982740	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs560024151	chr5:4982782-4982783	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs77070092	chr5:4982790-4982791	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs40468	chr5:4982814-4982815	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs79981423	chr5:4982816-4982817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs372494556	chr5:4982875-4982876	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs529625618	chr5:4982936-4982937	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs185818152	chr5:4982966-4982967	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs189939409	chr5:4982999-4983000	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs548217328	chr5:4983036-4983037	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs374021279	chr5:4983044-4983045	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs149833261	chr5:4983104-4983105	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs548487311	chr5:4983201-4983202	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537175894	chr5:4983241-4983242	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs147507085	chr5:4983244-4983245	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs367611361	chr5:4983254-4983255	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs77317025	chr5:4983272-4983273	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs539667736	chr5:4983337-4983338	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs553584674	chr5:4983352-4983353	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs533647905	chr5:4983365-4983366	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs140235843	chr5:4983377-4983378	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs145659101	chr5:4983387-4983388	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs574564348	chr5:4983401-4983402	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs543507137	chr5:4983448-4983449	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs563260232	chr5:4983467-4983468	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs552125941	chr5:4983491-4983492	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs563609632	chr5:4983618-4983619	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs12513607	chr5:4983619-4983620	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs552695653	chr5:4983637-4983638	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs181526166	chr5:4983642-4983643	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs7722176	chr5:4983657-4983658	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs528422774	chr5:4983662-4983663	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs548156597	chr5:4983683-4983684	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs7701846	chr5:4983701-4983702	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs112702093	chr5:4983713-4983714	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs73041818	chr5:4983727-4983728	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs550634482	chr5:4983774-4983775	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs12521561	chr5:4983778-4983779	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs142494699	chr5:4983801-4983802	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs570945885	chr5:4983811-4983812	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs115233636	chr5:4983831-4983832	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs114276746	chr5:4983869-4983870	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs187011822	chr5:4983882-4983883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:94)

Disease	PMID	Source
Glioblastoma multiforme	22286061	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Schizophrenia	23813976	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:209 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:4978600-4982800	Weak transcription	Ovary	ovary
2	chr5:4981800-4982800	Weak transcription	Fetal Kidney	kidney
3	chr5:4982800-4983800	Enhancers	Fetal Kidney	kidney
4	chr5:4982800-4984400	Enhancers	Ovary	ovary
5	chr5:4983200-4983800	Enhancers	Fetal Lung	lung
6	chr5:4983400-4984000	Enhancers	Fetal Stomach	stomach
7	chr5:4983800-4984200	Weak transcription	Fetal Kidney	kidney
8	chr5:4984000-4984200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
9	chr5:4984000-4984200	Enhancers	Brain Hippocampus Middle	brain
10	chr5:4984000-4985200	Enhancers	Brain Inferior Temporal Lobe	brain
11	chr5:4984000-4985200	Enhancers	Brain Substantia Nigra	brain
12	chr5:4984000-4986000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr5:4984000-4990600	Weak transcription	Fetal Stomach	stomach
14	chr5:4984200-4984400	Enhancers	Fetal Kidney	kidney
15	chr5:4984200-4984800	Weak transcription	Brain Hippocampus Middle	brain
16	chr5:4984200-4985200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr5:4984400-4985400	Weak transcription	Fetal Kidney	kidney
18	chr5:4984400-4987200	Weak transcription	Ovary	ovary
19	chr5:4985000-4985400	Enhancers	Brain Hippocampus Middle	brain
20	chr5:4985000-4985400	Enhancers	Pancreas	Pancrea
21	chr5:4985200-4986000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr5:4985400-4986000	Enhancers	Fetal Kidney	kidney
23	chr5:4985400-4990200	Weak transcription	Pancreas	Pancrea
24	chr5:4986000-4987200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr5:4986000-4987200	Weak transcription	Fetal Kidney	kidney
26	chr5:4987200-4987400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
27	chr5:4987200-4988200	Enhancers	Ovary	ovary
28	chr5:4987200-4992400	Enhancers	Fetal Kidney	kidney
29	chr5:4987400-4988200	Enhancers	Adipose Nuclei	Adipose
30	chr5:4988000-4988200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr5:4988200-4989400	Weak transcription	Adipose Nuclei	Adipose
32	chr5:4988200-4990000	Weak transcription	Ovary	ovary
33	chr5:4988200-4991000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr5:4988800-4990200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr5:4989400-4989600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr5:4989400-4991000	Enhancers	Adipose Nuclei	Adipose
37	chr5:4989600-4994600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr5:4990000-4991200	Enhancers	Ovary	ovary
39	chr5:4990200-4990400	Enhancers	Pancreas	Pancrea
40	chr5:4990600-4991200	Enhancers	Fetal Stomach	stomach
41	chr5:4991000-4995000	Weak transcription	Adipose Nuclei	Adipose
42	chr5:4991000-4995400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr5:4991200-4992200	Weak transcription	Ovary	ovary
44	chr5:4992200-4992600	Enhancers	Ovary	ovary
45	chr5:4993800-4994000	Enhancers	Fetal Kidney	kidney
46	chr5:4994600-4995400	Enhancers	HSMM	muscle
47	chr5:4994600-4995800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr5:4994600-4996000	Enhancers	Osteobl	bone
49	chr5:4994800-4995600	Enhancers	Muscle Satellite Cultured Cells	--
50	chr5:4994800-4995800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links